Table 4 Sensitivity analysis results. Costs in SEK 2004.

Base case

6,522 134

-70,985

35

<0

Model parameters

A. Fracture risk [39]

6,479,356

-28,207

35

<0

A. Fracture risk doubled

5,978,641

472,508

33

14,327

B. Mortality risk [40]

7,401,024

-949,875

29

<0

C. Medical treatment costs [21]

11,793,758

-5,342,609

35

<0

C. Medical treatment costs, average difference

6,420,258

30,891

35

879

1 year before and 2 years after hip fracture

D. 2^nd and following year costs [21]

6,709,090

-257,941

35

<0

E. Non-market productivity incl. [41]

6,789,172

-338,023

35

<0

E. Costs in added life-years [14]

447,200

6,003,949

35

170,907

F. Alternative QoL weights [42]

6,522,134

-70,989

48

<0

G. Discount rate 0%

7,535,125

-1,083,976

45

<0

G. Discount rate 5%

5,986,099

465,050

30

15,313

H. Mortality and hip fracture risks [39,40]

7,385,325

-934,176

29

<0

I. No costs or QoL effects after 1st year

1,935,529

4,515,620

22

202,041

J. Another disease; fracture risks doubled, no costs or QoL effects after 1st year

1,730,899

4,720,250

21

228,805

Program specific

Program costs +25%

6,522,134

1,541,798

35

43,888

Program effectiveness: lowest

2,712,870

3,738,279

21

178,013

Program effectiveness: highest

12,534,792

-6,083,643

67

<0